# Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

> **NCT06278402** · PHASE3 · COMPLETED · sponsor: **Jinnah Hospital** · enrollment: 30 (actual)

## Conditions studied

- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis

## Interventions

- **DRUG:** Tofacitinib

## Key facts

- **NCT ID:** NCT06278402
- **Lead sponsor:** Jinnah Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2024-01-06
- **Final completion:** 2024-01-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06278402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06278402, "Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06278402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*